Literature DB >> 31799897

miRNA transfection via poly(amidoamine)-based delivery vector prevents hypoxia/reperfusion-induced cardiomyocyte apoptosis.

Nida Sayed1, Prajakta Tambe1, Pramod Kumar1, Sachin Jadhav1, Kishore M Paknikar1,2,3, Virendra Gajbhiye1.   

Abstract

Aim: Myocardial infarction is a tissue injury that leads to apoptosis of cardiomyocytes. This can be prevented by using miRNAs, but its delivery to cardiomyocytes is a major hurdle. We aimed to deliver miRNAs using poly(amidoamine)-histidine (PAMAM-His) nanocarriers to prevent apoptosis. Materials & methods: The PAMAM-His nanoparticles were synthesized and assessed for their transfection efficiency of miRNAs to prevent apoptosis in hypoxia/reperfusion-induced H9c2 as well as primary cultured cardiomyocytes. Results & conclusion: miRNAs-nanoparticle complexes exerted a significant antiapoptotic effect on the H9c2 and primary rat ventricular cardiomyocytes. Enhanced expression of antiapoptotic genes and decreased expression of proapoptotic genes were observed. PAMAM-His nanoparticles effectively delivered miRNAs to the cardiomyocytes and prevented the hypoxia/reperfusion-induced apoptosis critical in myocardial infarctions.

Entities:  

Keywords:  PAMAM dendrimers; RNA interference; cardiomyocytes; hypoxia/reperfusion injury; miRNA; myocardial infarction

Year:  2019        PMID: 31799897     DOI: 10.2217/nnm-2019-0363

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  6 in total

1.  Circular RNA Fbxl5 Regulates Cardiomyocyte Apoptosis During Ischemia Reperfusion Injury via Sponging microRNA-146a.

Authors:  Dongjiu Li; Jiayin You; Chengyu Mao; En Zhou; Zhihua Han; Junfeng Zhang; Tiantian Zhang; Changqian Wang
Journal:  J Inflamm Res       Date:  2022-04-21

Review 2.  Nanotechnology for cardiovascular diseases.

Authors:  Qinqin Hu; Zheyan Fang; Junbo Ge; Hua Li
Journal:  Innovation (Camb)       Date:  2022-02-02

Review 3.  De novo Drug Delivery Modalities for Treating Damaged Hearts: Current Challenges and Emerging Solutions.

Authors:  Syed Baseeruddin Alvi; Salmman Ahmed; Divya Sridharan; Zahra Naseer; Nooruddin Pracha; Henry Wang; Konstantinos Dean Boudoulas; Wuqiang Zhu; Nazish Sayed; Mahmood Khan
Journal:  Front Cardiovasc Med       Date:  2021-09-28

Review 4.  miRNA Delivery by Nanosystems: State of the Art and Perspectives.

Authors:  Fernanda C Moraes; Chantal Pichon; Didier Letourneur; Frédéric Chaubet
Journal:  Pharmaceutics       Date:  2021-11-09       Impact factor: 6.525

Review 5.  Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases.

Authors:  Fangyu Yang; Jianjiang Xue; Guixue Wang; Qizhi Diao
Journal:  Front Pharmacol       Date:  2022-09-12       Impact factor: 5.988

Review 6.  Current Updates on Potential Role of Flavonoids in Hypoxia/Reoxygenation Cardiac Injury Model.

Authors:  Shafreena Shaukat Ali; Liza Noordin; Ruzilawati Abu Bakar; Satirah Zainalabidin; Zakiah Jubri; Wan Amir Nizam Wan Ahmad
Journal:  Cardiovasc Toxicol       Date:  2021-06-10       Impact factor: 3.231

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.